Advisory Board and Editors Neuroscience

Journal Factsheet
A one-page PDF to help when considering journal options with co-authors
Download Factsheet
I told my colleagues that PeerJ is a journal where they need to publish if they want their paper to be published quickly and with the strict peer review expected from a good journal.
Sohath Vanegas,
PeerJ Author
View author feedback

Neil W. Kowall

Professor of Neurology and Pathology and Director, Boston University Alzheimer’s Disease Center, Boston University School of Medicine; Chief Neurology and Director of the VA New England Geriatric Research Education and Clinical Center, VA Boston Healthcare System.

Ziad Kronfol

Ziad Kronfol, M.D. is Professor of Psychiatry and Psychiatry Clerkship Director at Weill Cornell Medicine – Qatar. He previously was Associate Professor of Psychiatry and Director of the Psychoneuroimmunology Program at the University of Michigan in Ann Arbor. Dr. Kronfol is past Vice-President of the Asian Federation of Psychiatric Associations, Distinguished Life Fellow of the American Psychiatric Association and member of the section on education in the World Psychiatric Association.

M Fabiana Kubke

Senior Lecturer at the School of Medical Sciences (Department of Anatomy with Radiology) and member of the Centre for Brain Research at the University of Auckland in New Zealand. Interested in Neuroethology, Brain Evolution, Evo-Devo and auditory systems. Former Grass Fellow and Editorial board member of Brain Behavior and Evolution. Currently serving as an Academic Editor in PLOS ONE, and Chair of the Advisory Panel of Creative Commons Aotearoa New Zealand.

Susanne E la Fleur

Associate Professor at the Academic Medical Center, University of Amsterdam and Visiting Professor at Université Paris Diderot-Paris 7. Our group is working on unravelling the mechanistic link between diet composition and the development of obesity and diabetes as a first step towards better understanding the pathogenesis of Type 2 Diabetes Mellitus, focussing on the role of the brain.

Sharon La Fontaine

Senior Lecturer in Biomedical Science and Group Leader, Deakin University; Honorary Senior Research Fellow, The Florey Institute of Neuroscience and Mental Health.

Sharon's research has been funded by the NHMRC and ARC and is focused on the biology of the copper and its role in health and disease. Sharon has held research positions at The Murdoch Children’s Research Institute and at UCLA, USA, was a recipient of a prestigious NHMRC R.D. Wright Award and has published widely in internationally recognised journals. Sharon is a strong advocate for student professional development and career mentoring within the biomedical sciences and medical research through her University teaching and her work on the Victorian Branch of The Australian Society for Medical Research.

Angie R Laird

Dr. Laird received her Ph.D. in Physics from the University of Wisconsin in 2002, and was a faculty member at the University of Texas Health Science Center San Antonio from 2004-2012. She is currently an Associate Professor in Physics at Florida International University in Miami. Her neuroimaging and neuroinformatics research program is funded by the National Institutes of Mental Health and the National Science Foundation.

Renaud Lambiotte

Renaud Lambiotte is professor in the department of Mathematics of the University of Namur. He is interested in different aspects of complex systems, with a particular focus on complex networks. His recent research includes the development of algorithms to uncover information in large-scale networks, the study of empirical data in social and neuronal systems, and the mathematical modelling of human mobility and diffusion on networks.

Giuseppe Lanza

Dr. Giuseppe Lanza was born in Catania (Italy) in 1982. He currently works as a Senior Academic Researcher and Assistant Professor at the University of Catania (Italy). After graduation with honours in Medicine, he trained at the School of Neurology and got the international PhD at the same University. As visiting Clinical Research Fellow, he further trained at the Department of Neuroscience and Clinical Neurophysiology of the Newcastle University (UK). In 2013 he was selected for a Scientific Fellowship promoted by the European Federation of Neurological Societies (EFNS). From 2013 to October 2018, he worked as a Consultant Neurologist at the “Oasi Research Institute–IRCCS” in Troina (Italy), which is a Collaborating Center of the World Health Organization (WHO), and where now he currently holds the position of Chief of the Clinical Neurophysiology Research Unit. From 2015 to October 2018, he taught Neurology at the University of Enna (Italy). He has authored more than 150 publications in internationally-indexed peer-reviewed Journals and Conferences or Meetings, and he currently serves as Editor and invited Reviewer of several international Journals. More recently, he has obtained the Master of Science in Clinical Research and the National Scientific Qualification as Full Professor (procedure for the Italian University Professor recruiting, based on criteria of scientific qualification).

B Duncan X Lascelles

After graduating from the veterinary program at the University of Bristol, U.K., with honors, Dr. Lascelles completed a PhD in aspects of pre-emptive/perioperative analgesia at the University of Bristol. After an internship there, he completed his surgical residency at the University of Cambridge, U.K. and then a Fellowship in Oncological Surgery at Colorado State University. He is currently Professor in Small Animal Surgery and Pain Management at North Carolina State University.

Corinne I. Lasmezas

Corinne Lasmézas, DVM, Ph.D. serves as a Professor at The Scripps Research Institute. Since Dr. Lasmézas' appointment at Scripps in 2005, she has focused on how misfolded proteins lead to neuronal dysfunction and loss in diseases including Alzheimer’s, Parkinson’s and prion diseases. Additionally, Dr. Lasmézas is a reviewer for national and private funding agencies worldwide, including the US National Institutes of Health (NIH) and the UK Medical Research Council and an Advisor for the US Food and Drug Administration (FDA), the US Environmental Protection Agency (EPA) and the US Department of Agriculture (USDA). Earlier in her career, Dr. Lasmézas’ research provided the first experimental evidence that the prion disease “mad cow disease” had been transmitted to humans, causing variant Creutzfeldt-Jakob disease. At the peak of the mad cow crisis, Dr. Lasmézas became an advisor to the World Health Organization (WHO) as well as several governmental and public health committees. She is multiple TED speaker and is an internationally recognized expert in the field of neurodegenerative diseases. She has published more than 60 original scientific papers. She has been a Member of Scientific Advisory Board at Anavex Life Sciences Corp. since March 2015. Dr. Lasmézas holds a PhD in Neurosciences from the University Pierre & Marie Curie in Paris and obtained her Doctorate of Veterinary Medicine and Diploma of Aeronautic and Space Medicine from the University of Toulouse, France.

Brittany N Lasseigne

Brittany N. Lasseigne, PhD is an Assistant Professor of Cell, Developmental and Integrative Biology at The University of Alabama at Birmingham School of Medicine. She trained in Biotechnology, Science, and Engineering at Mississippi State University (B.S.) and the University of Alabama in Huntsville (Ph.D.) and completed a postdoctoral fellowship in genetics and genomics at the HudsonAlpha Institute for Biotechnology.

Her lab develops and applies genomic- and data-driven strategies (including single-cell and long-read sequencing) to discover biological signatures that might be used to improve patient care and provide insight into the cellular and molecular processes contributing to disease, especially for diseases impacting the brain and/or kidney. Their recent work includes prioritizing drug repurposing candidates for cancers and polycystic kidney disease, evaluating preclinical models and cross-species transcriptomic signatures to improve disease modeling, and applying single-cell and long-read technologies to neurological disease tissues to understand the role that context plays in disease etiology, progression, and treatment.

The Lasseigne Lab is currently focused on integrating genomics data, functional annotations, and patient information with machine learning and regulatory network approaches across diseases that impact the brain or kidney to discover novel mechanisms in disease etiology and progression, identify genome-driven therapeutic targets and opportunities for drug repositioning and repurposing, determine clinically-relevant biomarkers, and understand how cellular context contributes to these diseases. Collectively, these distinct projects all apply genetics and genomics to human diseases and build tools to accelerate future research. Their lab also develops data science software and analytical pipelines that are open-source, well-documented, and hosted by third-party code distributors, critical for facilitating reproducibility and enabling the research community to use the methods they develop.

Andrew P Lavender

Senior Lecturer in the Institute of Health and Wellbeing, Federation University Australia. Dr Lavender completed a BSc and a MSc in Sport Science at Edith Cowan University and PhD at Yokohama City University. He is currently teaching applied research for exercise science and motor control and conducting research in exercise for healthy ageing, exercise induced muscle damage and eccentric training and sport related concussion and sub-concussion.